Part,  Chapter, Paragraph

 1    I,     2. 11    |            the nanolevel. Science, vol. 311, 622-627.~NIOSH (2006):
 2    I,     3.  4    |            Démographie européenne, vol.2: Dynamique démographique,
 3    I,     3.  4    |  Population: An English Selection, Vol. 21, No. 4: 303-316~ ~
 4   II,     5.  5.  2|       consensus study. The Lancet, Vol. 366, December 17/24/31~ ~
 5   II,     5.  5.  3|       Journal of Eating Disorders, Vol. 18, No. 4, 351-357.~Harper
 6   II,     5.  5.  3|       Adolescent Girls. PEDIATRICS Vol. 114 No. 6, 1574-1583.~NEDA (
 7   II,     8.  2.  1|  southeastern United States. JADA, Vol. 136, 903-012.~Prosser,
 8   II,     9.  1.  2|          Folic Acid?", The Lancet, Vol 369, pp 641-642.~Bianchi
 9   II,     9.  1.  2|         Defects Research (Part A), Vol 76, pp 693-705.~Bréart G,
10   II,     9.  1.  2|           Reproductive Toxicology, Vol 20, No 3, pp 393-402. ~Busby
11   II,     9.  1.  2|           British Medical Journal, Vol 330, pp 574-575.~Busby A,
12   II,     9.  1.  2|           British Medical Journal, Vol 331, pp 140-41. ~Cordier
13   II,     9.  1.  2|      Glycol Ethers", Epidemiology, Vol 8, No 4, pp 355-363.~Cordier
14   II,     9.  1.  2|              Environmental Health, Vol 18, pp 11-17.~De Walle HE,
15   II,     9.  1.  2|      Revues Epidem Sante Publique, Vol 53, pp 2S87-2S95.~Dolk H,
16   II,     9.  1.  2| Environmental Health Perspectives, Vol 112, No 3, pp 398-402.~Dolk
17   II,     9.  1.  2|          British Medical Bulletin, Vol 68, pp 25-45.~EUROCAT (2007):
18   II,     9.  1.  2|   Epidemiology & Community Health, Vol 45, No 1, pp 52-58.~Garne
19   II,     9.  1.  2|         Congenital Heart Diseases, Vol 2, pp 165-169.~Garne E,
20   II,     9.  1.  2|         Obstetrics and Gynecology, Vol 25, pp 6-11.~Garne E, Loane
21   II,     9.  1.  2|       Europe”, Prenatal Diagnosis, Vol 24, pp 908-12.~Garne E et
22   II,     9.  1.  2|    Prenatal and Neonatal Medicine, Vol 4, pp 441-447.~Green JM,
23   II,     9.  1.  2|       review. HTA Assessment 2004; Vol 8, no. 33.~Hansen M, Bower
24   II,     9.  1.  2|            Perinatal Epidemiology, Vol 21, pp 363-369.~Macintosh
25   II,     9.  1.  2|         Anomaly”, Arch Dis Childh, Vol 82, pp 349-352.~Waller K,
26   II,     9.  2.  7|            Birthweight. NeoReviews Vol.5 No.12 2004 e522. American
27   II,     9.  3.  3|      behaviour of young Europeans. Vol.1 Population Studies Council
28   II,     9.  4.  7|            England, Health Trends. vol. 25, pp. 3137.~ ~International
29   II,     9.  4.  7|            adults. Age and Ageing. vol. 35, 103-105.~ ~Rathmann
30   II,     9.  5.  6|          Science & Medicine, 2005 (Vol. 61) (No. 10) 2221-2232~
31   II,     9.  5.  6|        Journal of Women’s Studies, Vol 12(3): 377-395; SAGE Publications~ ~
32  III,    10.  2.  1|           Journal of Public Health Vol. 14(2):103-109.~ ~Greyling
33  III,    10.  2.  1|       selected major risk factors. Vol. 1. (Edited by: Ezzati M,
34  III,    10.  2.  4|           shared controls. Nature, Vol 447:661-678~ ~Zika E, Papatryfon
35  III,    10.  3.  1|            miners. Health Physics, vol.92, no. 4, 371-8.~Lucas
36  III,    10.  3.  1|            cohort. Health Physics, vol.92, no. 2,157-169.~Website
37  III,    10.  3.  2| Environmental Health Perspectives, Vol 113(9). Available at: htt ~ ~
38  III,    10.  4.  2|             Ecotoxicol Environ Saf Vol. 63: 100-7~ ~RIVM (2006):
39  III,    10.  5.  1|         participation. In: Cities. Vol. 23. Issue 5. P. 339352.~
40  III,    10.  5.  1|      Health. Washington: Feb 2003, vol 93, p 288~Said B et al.
41  III,    10.  5.  1|          Journal of Public Health, Vol. 16, No. 6, 583–591;~ ~Wargocki